Volume 65 Issue 22-March-April 2025 : Feature

In the ongoing global fight against infectious diseases, vaccines stand out as one of the most powerful tools for preventing illness and saving lives. However, significant barriers still impede access to these life-saving interventions, particularly across Africa.

In a recent interview with Kutlwano, Dr John Tlhakanelo, a public health physician and health economist at the University of Botswana, sheds light on the dual challenges of poor access and vaccine hesitancy within African communities, particularly concerning COVID-19 vaccines. 

Dr Tlhakanelo points out that, even when vaccines are available, certain populations remain hesitant to participate in vaccination programmes. “This reluctance, especially among younger individuals, is influenced by factors such as mistrust, religious beliefs, and the spread of conspiracy theories,” he explains. He cites findings from the Equitable Access to COVID-19 Vaccines in Botswana (ECOVA) Study, which indicates that negative beliefs surrounding the COVID-19 vaccines particularly affect younger demographics.

The study reveals prevalent sentiments of mistrust toward government institutions, the role of religious convictions, and the rampant dissemination of misinformation via social media. Dr Tlhakanelo emphasises the urgent need to address these concerns to enhance vaccination uptake and safeguard public health.

A significant challenge highlighted by Dr  Tlhakanelo is the detrimental role social media plays in amplifying misinformation. “The rise of social media platforms has created echo chambers where individuals are predominantly exposed to content that aligns with their pre-existing beliefs about vaccines,” he notes. To combat this issue, he advocates for innovative strategies aimed at countering misinformation and ensuring the availability of accurate information.

Improving vaccine access also necessitates effective stakeholder engagement and collaboration. “A coordinated approach involving government bodies, non-governmental organizations (NGOs), donors, and local communities is vital for distributing vaccines equitably and effectively,” Dr Tlhakanelo asserts. He contends that establishing a system aligned toward a common goal will facilitate more efficient vaccine delivery, ultimately boosting public health outcomes.

Dr Tlhakanelo praises the efforts of the African Health Economics and Policy Association (AfHEA) and its partners in promoting vaccine equity across the continent, particularly their work to ensure Africa’s self-sufficiency in vaccine production and pandemic response, a priority that gained momentum during the COVID-19 pandemic.

In 2024, AfHEA, in collaboration with the Africa Centres for Disease Control and Prevention (Africa CDC), the International Development and Research Centre (IDRC), and the United Nations Economic Commission for Africa (UNECA), conducted the ECOVA study. This research aimed to enhance vaccine access for vulnerable populations in Botswana, involving a review of local studies and interviews with key stakeholders.

The ECOVA findings show a national adult COVID-19 vaccine acceptance rate of 73.4 percent, with interesting gender-based disparities observed; men showed a higher likelihood of vaccine acceptance than women. This disparity indicates the need for targeted interventions to address the unique barriers women face in accessing healthcare services.

During a validation workshop held on January 29 at Woodlane Hotel, stakeholders from government and NGOs came together to discuss solutions for improving vaccine delivery. A significant recommendation was to secure sustainable funding mechanisms for vaccination campaigns, especially during pandemics.

Further proposals included developing targeted community engagement programs that collaborate with community leaders and social media influencers to promote vaccine acceptance. One notable suggestion was to integrate gender perspectives into vaccination strategies, recognizing the specific barriers women encounter.

Participants also advocated reviewing Botswana’s vaccination policies and guidelines to enhance preparedness for future pandemics. Regional collaboration emerged as another crucial measure, emphasizing the importance of harnessing Africa’s vaccine manufacturing capabilities to bolster responses to health crises.

The challenges highlighted by Dr Tlhakanelo and his colleagues illustrate the complexity of ensuring equitable vaccine access while also providing a roadmap for overcoming these obstacles. By fostering collaboration, countering misinformation, and catering to the needs of vulnerable populations, Africa can advance towards a healthier future.

Dr Tlhakanelo notes that the lessons learned from COVID-19 vaccination campaigns are invaluable for shaping Africa’s strategy for future health emergencies. He asserts that the ongoing efforts of stakeholders, including AfHEA and its partners, are crucial for the continent’s progress toward self-sufficiency in vaccine production and effective pandemic response.

“Through collective efforts, Africa can make significant strides in reducing morbidity and mortality from vaccine-preventable diseases, ultimately improving the health and well-being of millions across the continent,” says  Dr Tlhakanelo. ENDS

Buy Online Now!